Main Article Content
The rapid spreading of COVID-19 globally has extensively brought many consequences on care particularly for diabetes patients who are the large group of chronic illness in the world. Many diabetes patients are experiencing barrier of care due to the policy related to COVID-19 prevention. Diabetes risk to chronic complication, severe complication and increase motality. This article aims to review the evidence of nursing care on diabetes management, specific considerations during the COVID-19 pandemic for people living with diabetes and role of nusres.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Boromarajonani College of Nursing, Uttaradit Journal attribution-non-commercial 4.0 international (CC BY-NC 4.0). For more detail please visit https://creativecommons.org/licenses/by-nc/4.0/ . The ideas and opinions expressed in the Boromarajonani College of Nursing, Uttaradit are those of the authors and not necessarily those of the editor .
Brufsky, A. (2020). Hypecerglymia, Hydroxychloroquine, and the COVID-19 pandemic. Journal of Medical Virology, 92(7), 770–775.
Cariou, B, Hadjadj, S, Wargny, M, Pichelin, M., Al-Salameh,A., Allix,I... Gourdy, P. (2020). Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 63,1500–1515. doi: 10.1007/s00125-020-05180-x..
Cox, E. (2020). World Diabetes Day 2020: nursing education and care. Retrieved .(2020, November 12). from
Chen, SC., Lai, YH., & Tsay, SL. (2020). Nursing perspectives on the impacts of COVID-19.Journal of Nursing Research, 28(3), e85. doi: 10.1097/jnr.0000000000000389
Delgado-Roche, L. & Mesta, F. (2020). Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Archives of Medical Research, 51(5), 384–387.
Department of Desease Control. (2021). Coronavirus Disease Situation Report 2019. Retrieved (2021, May 8) from: https://ddc.moph.go.th/viralpneumonia/file/situation/situation-no491-080564.pdf (in Thai).
Department of Mental Health. (2020). Combat 4th wave of COVID-19: C4. Bangkok: A1 Printing. (in Thai).
Elnaem, M. H., & Cheema, E. (2021). Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists. Research in Social & Administrative Pharmacy. Research in Social and Administrative Pharmacy, 17(1), 1938–1941.
Faghir-Gangi, M., Moameri, H, Abdolmohamadi, N, & Nematollahi SH. (2020). The prevalence of type 2 diabetes in patients with COVID 19: a systematic review and meta-analysis. Via Medica, 9(5), 271–278.
Flores-Luevano, S., Pacheco, M., Shokar, G. S., Dwivedi, A. K., & Shokar, N. K. (2020). Impact of a culturally tailored diabetes education and empowerment program in a Mexican American population along the US/Mexico border: a pragmatic study. Journal of clinical medicine research, 12(8), 517–529. doi.org/10.14740/jocmr4273
Garg, S., & Norman, G. J. (2021). Impact of COVID-19 on health economics and technology of diabetes care: use cases of real-time continuous glucose monitoring to transform health care during a global pandemic. Diabetes Technology & Therapeutics, 23(S1), S15–S20. https://doi.org/10.1089/dia.2020.0656.
Hyun, KS, Kim, KM, & Jang, SH. (2009). The effects of tailored diabetes education on blood glucose control and self-care. Journal of Korean Academy of Nursing, 39(5),720- 730. Korean. doi: 10.4040/jkan.2009.39.5.720. PMID: 19901502.
Joint statement by ILO, FAO, IFAD and WHO. (2020). Impact of COVID-19 on people's livelihoods, their health and our food systems. Retrieved (2020, October 13) from https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people's livelihoods-their-health-and-our-food-systems#:~:text=The%20economic% 20and%20social%20disruption,the%20end%20of%20the%20year
Lacobellis, G. (2020). COVID-19 and diabetes: can DPP4 inhibition play a role? Diabetes Research and Clinical Practice, 162,108125. doi: 10.1016/j.diabres.2020.108125.
Lea-Henry T.N., Baird-Gunning J., Petzel E.,& Roberts D.M. (2017). Medication management on sick days. Australian Prescriber, 40(5), 168–173. doi: 10.18773/austprescr.2017.057.
Lim, S., Bae, J.H., Kwon, HS. , Nauck.MA. (2021). COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews Endocrinology, 17, 11– 30 doi.org/10.1038/s41574-020-00435-4
Muralidharan, S., Ranjani, H., Anjana, R. M., Allender, S., & Mohan, V. (2017). Mobile health technology in the prevention and management of type 2 diabetes. Indian Journal of Endocrinology and Metabolism, 21(2), 334–340.
Nerpin, E., Toft, E., Fischier, J., Lindholm-Olinder, A., & Leksell, J. (2020). A virtual clinic for the management of diabetes-type 1: study protocol for a randomised wait-list controlled clinical trial. BMC Endocrine Disorder, 20, 137 doi.org/10.1186/s12902-020-00615-3.
Nikitara, M., Constantinou, C. S., Andreou, E., & Diomidous, M. (2019). The role of nurses and the facilitators and Barriers in diabetes care: a mixed methods systematic literature review. Behavioral sciences (Basel, Switzerland), 9(6), 61. doi.org/10.3390/bs9060061.
Orioli, L., Hermans, MP., Thissen, JP., Maiter, D., Vandeleene, B., & Yombi, JC. (2020).COVID-19 in diabetic patients:
Related risks and specifics of management. Annales d’Endocrinologie (Paris), 81(2-3),101-109. doi: 10.1016/j.ando.2020.05.001. PMID: 32413342; PMCID: PMC7217100.
Papachristou, S., Stamatiou,I., Stoian, A.P.,& Papanas, N. (2021). New-onset diabetes in COVID-19: time to frame its fearful symmetry. Diabetes Therapy, 12(2), 461–464. doi: 10.1007/s13300-020-00988-7.
Reddy PK, Kuchay MS, Mehta Y, Mishra SK. (2020). Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature. Diabetes Metabolic Syndrome, 14,1459–1462. doi: 10.1016/j.dsx.2020.07.050.
Saqib, M., Siddiqui, S., Qasim, M., Jamil, M. A., Rafique, I., Awan, U. A., Ahmad, H., & Afzal, M. S. (2020). Effect of COVID-19 lockdown on patients with chronic diseases. Diabetes & Metabolic Syndrome, 14(6), 1621–1623.
Shi Q, ZX., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J...Wang, W. (2020). Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care, 43(7), 1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14. PMID: 32409504.
Singh, AK, & Singh, R. (2020). Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Research and Clinical Practice, 167, 108382. doi: 10.1016/j.diabres.2020.108382.
WHO. (2021). Diabetes. Retrieved (2021, April 13) from https://www.who.int/news- room/fact-sheets/detail/diabetes
Wicaksana, A.L., Hertanti, N. S., Ferdiana, A., & Pramono, R. B. (2020). Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: a scoping review. Diabetes & metabolic syndrome, 14(5), 1109–1120. https://doi.org/10.1016/j.dsx.2020.06.070
Wu, Z. & McGoogan, J. M. (2020).Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. The Journal of the American Medical Association,323, 1239–1242.
Yaribeygi,H, Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A (2020). The impact of diabetes mellitus in COVID-19: a mechanistic review of molecular interactions. Journal of Diabetes Research, ID 5436832, https://doi.org/10.1155/2020/5436832